Inspira™ to exhibit the fda cleared inspira™ art100 system at a world-renowned event in the sector

The event is an opportunity to present and demonstrate new products and technologies to potential customers and strategic partners ra'anana, israel , june 5, 2024 /prnewswire/ -- inspira™ technologies oxy b.h.n. ltd. (nasdaq: iinn) (nasdaq: iinnw) (the "company" or "inspira technologies"), a breakthrough medical technology company, is proud to announce plans to exhibit the inspira™ art100 system, recently cleared by the u.s. food and drug administration ("fda"), at the extracorporeal life support organization (elso) conference in detroit, michigan between september 29 to october 1, 2024.
IINN Ratings Summary
IINN Quant Ranking